Challenges and Opportunities of Nanomedicine Approaches to Induce Immune Tolerance and Cure Type...

preview_player
Показать описание
Challenges and Opportunities of Nanomedicine Approaches to Induce Immune Tolerance and Cure Type 1 Diabetes

Dr. José M Carballido, Executive Director, Translational Research Fellow at Novartis Institutes for BioMedical Research Basel (CH)

21. Nanomedicine in and against Infection and Inflammation
CLINAM 2018
11th European and Global Summit for Clinical
Nanomedicine, Targeted Delivery and Precision Medicine
Hall Sydney
4.9.18
Рекомендации по теме